These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1084929)

  • 41. Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.
    Sasaki T; Shibata S; Hirabayashi Y; Sekiguchi Y; Yoshinaga K
    Clin Exp Immunol; 1989 Jul; 77(1):37-42. PubMed ID: 2788540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased double marker lymphocytes in systemic lupus erythematosus and lymphoproliferative disorders.
    Niwa Y; Ou DW; Waterhouse JP; Yokoyama MM; Miyake S
    J Clin Lab Immunol; 1982 Feb; 7(2):105-10. PubMed ID: 6978406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ontogeny of T cells, B cells and monocytes in the bovine foetus.
    Senogles DR; Paul PS; Johnson DW; Muscoplat CC
    Clin Exp Immunol; 1979 May; 36(2):299-303. PubMed ID: 314369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID).
    Farrant J; Spickett G; Matamoros N; Copas D; Hernandez M; North M; Chapel H; Webster AD
    Immunodeficiency; 1994; 5(2):159-69. PubMed ID: 7913365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies for T lymphocytes in systemic lupus erythematosus.
    Michlmayr G; Pathouli C; Huber C; Huber H
    Clin Exp Immunol; 1976 Apr; 24(1):18-25. PubMed ID: 1084815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
    Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
    J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus.
    Miyoshi Y; Kilpatrick KA; Kelley RO; Searles RP; Williams RC
    J Rheumatol; 1985 Dec; 12(6):1097-104. PubMed ID: 4093915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased lymphocyte death by neglect-apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations.
    Silva LM; Garcia AB; Donadi EA
    J Neurol; 2002 Aug; 249(8):1048-54. PubMed ID: 12195452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-DNA antibodies react with DNA expressed on the surface of monocytes and B lymphocytes.
    Bennett RM; Davis J; Merritt M
    J Rheumatol; 1986 Aug; 13(4):679-85. PubMed ID: 3490571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of prednisolone and azathioprine on T- and B-lymphocyte number in peripheral blood of patients with glomerulonephritis and systemic lupus erythematosus].
    Shilov EM; Tareeva IE; Gordovskaia NB
    Ter Arkh; 1978; 50(6):60-7. PubMed ID: 307828
    [No Abstract]   [Full Text] [Related]  

  • 55. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison between anti-lymphocyte antibodies in systemic lupus erythematosus and in Hodgkin's disease].
    Del Giacco GS; Leone AL; Locci F; Manconi PE; Tognella S; Mantovani G; Grifoni V
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):255-61. PubMed ID: 1087885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of T lymphocytes in systemic lupus erythematosus].
    Zubler RH; Miescher PA
    Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-surface modifications of normal human peripheral lymphocytes induced by lymphocytotoxic sera of patients with systemic lupus erythematosus and Hodgkin's disease, studied by scanning electron microscopy.
    Del Giacco GS; Riva A; Loy M; Batzella MG; Cengiarotti L; Leone AL; Locci F; Murru V
    Haematologica; 1979 Apr; 64(2):148-58. PubMed ID: 112006
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus.
    Traycoff RB; Rogers WW; Gregory SA
    J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.